ID   BGAT_HUMAN              Reviewed;         354 AA.
AC   P16442; B0JDB9; O14758; Q14490; Q53I57; Q6ISD4; Q6KFZ2; Q70V27;
AC   Q99484; Q99485; Q9NY01; Q9UQ68; Q9UQ69;
DT   01-AUG-1990, integrated into UniProtKB/Swiss-Prot.
DT   01-DEC-1992, sequence version 2.
DT   24-JUN-2015, entry version 173.
DE   RecName: Full=Histo-blood group ABO system transferase;
DE   AltName: Full=Fucosylglycoprotein 3-alpha-galactosyltransferase;
DE   AltName: Full=Fucosylglycoprotein alpha-N-acetylgalactosaminyltransferase;
DE   AltName: Full=Glycoprotein-fucosylgalactoside alpha-N-acetylgalactosaminyltransferase;
DE            EC=2.4.1.40;
DE   AltName: Full=Glycoprotein-fucosylgalactoside alpha-galactosyltransferase;
DE            EC=2.4.1.37;
DE   AltName: Full=Histo-blood group A transferase;
DE            Short=A transferase;
DE   AltName: Full=Histo-blood group B transferase;
DE            Short=B transferase;
DE   AltName: Full=NAGAT;
DE   Contains:
DE     RecName: Full=Fucosylglycoprotein alpha-N-acetylgalactosaminyltransferase soluble form;
GN   Name=ABO;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND PARTIAL PROTEIN SEQUENCE.
RX   PubMed=2104828;
RA   Yamamoto F., Marken J., Tsuji T., White T., Clausen H., Hakomori S.;
RT   "Cloning and characterization of DNA complementary to human UDP-
RT   GalNAc: Fuc alpha 1-->2Gal alpha 1-->3GalNAc transferase (histo-blood
RT   group A transferase) mRNA.";
RL   J. Biol. Chem. 265:1146-1151(1990).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=2333095; DOI=10.1038/345229a0;
RA   Yamamoto F., Clausen H., White T., Marken J., Hakomori S.;
RT   "Molecular genetic basis of the histo-blood group ABO system.";
RL   Nature 345:229-233(1990).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], POLYMORPHISM, AND VARIANT LEU-156.
RX   PubMed=7598760; DOI=10.1006/bbrc.1995.1044;
RA   Bennett E.P., Steffensen R., Clausen H., Weghuis D.O.,
RA   Geurts van Kessel A.;
RT   "Genomic cloning of the human histo-blood group ABO locus.";
RL   Biochem. Biophys. Res. Commun. 206:318-325(1995).
RN   [4]
RP   ERRATUM.
RX   PubMed=7779106; DOI=10.1006/bbrc.1995.1817;
RA   Bennett E.P., Steffensen R., Clausen H., Weghuis D.O.,
RA   Geurts van Kessel A.;
RL   Biochem. Biophys. Res. Commun. 211:347-347(1995).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA], POLYMORPHISM, AND VARIANTS
RP   LEU-156; GLY-176; SER-235 AND MET-266.
RA   Yamamoto F.;
RT   "Human histo-blood group ABO gene locus alleles.";
RL   Submitted (MAR-1999) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   TISSUE=Peripheral blood;
RX   PubMed=16533287; DOI=10.1111/j.1537-2995.2006.00740.x;
RA   Seltsam A., Das Gupta C., Bade-Doeding C., Blasczyk R.;
RT   "A weak blood group A phenotype caused by a translation-initiator
RT   mutation in the ABO gene.";
RL   Transfusion 46:434-440(2006).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   TISSUE=Peripheral blood;
RX   PubMed=17764507; DOI=10.1111/j.1537-2995.2007.01475.x;
RA   Seltsam A., Wagner F.F., Gruger D., Gupta C.D., Bade-Doeding C.,
RA   Blasczyk R.;
RT   "Weak blood group B phenotypes may be caused by variations in the
RT   CCAAT-binding factor/NF-Y enhancer region of the ABO gene.";
RL   Transfusion 47:2330-2335(2007).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], POLYMORPHISM, AND VARIANTS ARG-230;
RP   SER-235; MET-266 AND ALA-268.
RC   TISSUE=Peripheral blood;
RX   PubMed=18513251; DOI=10.1111/j.1537-2995.2008.01782.x;
RA   Seltsam A., Gruger D., Just B., Figueiredo C., Gupta C.D.,
RA   Deluca D.S., Blasczyk R.;
RT   "Aberrant intracellular trafficking of a variant B
RT   glycosyltransferase.";
RL   Transfusion 48:1898-1905(2008).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], POLYMORPHISM, AND VARIANTS ARG-35;
RP   PHE-36; HIS-63; SER-74; LEU-156; HIS-161; GLY-176; CYS-199; ILE-216;
RP   SER-235; MET-266; ALA-268 AND MET-277.
RG   SeattleSNPs variation discovery resource;
RL   Submitted (APR-2003) to the EMBL/GenBank/DDBJ databases.
RN   [10]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], POLYMORPHISM, AND VARIANTS
RP   GLY-176; SER-235; MET-266 AND ALA-268.
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [11]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 11-354, POLYMORPHISM, AND
RP   VARIANTS SER-74; LEU-156; MET-163; GLY-176; SER-235; MET-266; ALA-268;
RP   ARG-268; ARG-288 AND MET-346.
RX   PubMed=12829588; DOI=10.1182/blood-2003-03-0955;
RA   Seltsam A., Hallensleben M., Kollmann A., Blasczyk R.;
RT   "The nature of diversity and diversification at the ABO locus.";
RL   Blood 102:3035-3042(2003).
RN   [12]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 81-354, POLYMORPHISM, AND
RP   VARIANTS LEU-156; GLY-176; ARG-214; ILE-216; ASP-223; SER-235;
RP   MET-266; ALA-268; MET-277; ASN-291; GLY-352 AND TRP-352.
RX   PubMed=8839869;
RA   Ogasawara K., Yabe R., Uchikawa M., Saitou N., Bannai M., Nakata K.,
RA   Takenaka M., Fujisawa K., Ishikawa Y., Juji T., Tokunaga K.;
RT   "Molecular genetic analysis of variant phenotypes of the ABO blood
RT   group system.";
RL   Blood 88:2732-2737(1996).
RN   [13]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 81-354.
RX   PubMed=9800297; DOI=10.1046/j.1365-3148.1998.00161.x;
RA   Olsson M.L., Chester M.A.;
RT   "Heterogeneity of the blood group Ax allele: genetic recombination of
RT   common alleles can result in the Ax phenotype.";
RL   Transfus. Med. 8:231-238(1998).
RN   [14]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 11-354, POLYMORPHISM, AND
RP   VARIANTS GLY-176; SER-235; MET-266 AND ALA-268.
RX   PubMed=15104652; DOI=10.1111/j.1537-2995.2004.03346.x;
RA   Roubinet F., Despiau S., Calafell F., Jin F., Bertanpetit J.,
RA   Saitou N., Blancher A.;
RT   "Evolution of the O alleles of the human ABO blood group gene.";
RL   Transfusion 44:707-715(2004).
RN   [15]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 126-354, POLYMORPHISM, AND
RP   VARIANTS GLY-176; SER-235 AND MET-346.
RA   Seltsam A., Hallensleben M., Salama A., Blasczyk R.;
RT   "A novel B Transferase.";
RL   Submitted (MAR-2000) to the EMBL/GenBank/DDBJ databases.
RN   [16]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 146-334, POLYMORPHISM, AND
RP   VARIANTS MET-266 AND ALA-268.
RX   PubMed=1449469; DOI=10.1016/0006-291X(92)91538-2;
RA   Kominato Y., McNeill P.D., Yamamoto M., Russell M., Hakomori S.,
RA   Yamamoto F.;
RT   "Animal histo-blood group ABO genes.";
RL   Biochem. Biophys. Res. Commun. 189:154-164(1992).
RN   [17]
RP   CHARACTERIZATION, AND POLYMORPHISM.
RX   PubMed=2121736;
RA   Yamamoto F., Hakomori S.;
RT   "Sugar-nucleotide donor specificity of histo-blood group A and B
RT   transferases is based on amino acid substitutions.";
RL   J. Biol. Chem. 265:19257-19262(1990).
RN   [18]
RP   POLYMORPHISM, AND VARIANT ALA-234.
RX   PubMed=10462501; DOI=10.1006/bbrc.1999.1246;
RA   Yu L.C., Lee H.L., Chan Y.S., Lin M.;
RT   "The molecular basis for the B(A) allele: an amino acid alteration in
RT   the human histoblood group B alpha-(1,3)-galactosyltransferase
RT   increases its intrinsic alpha-(1,3)-N-acetylgalactosaminyltransferase
RT   activity.";
RL   Biochem. Biophys. Res. Commun. 262:487-493(1999).
RN   [19]
RP   X-RAY CRYSTALLOGRAPHY (1.35 ANGSTROMS) OF 64-354, METAL-BINDING, AND
RP   MUTAGENESIS OF GLU-303.
RX   PubMed=12198488; DOI=10.1038/nsb832;
RA   Patenaude S.I., Seto N.O.L., Borisova S.N., Szpacenko A., Marcus S.L.,
RA   Palcic M.M., Evans S.V.;
RT   "The structural basis for specificity in human ABO(H) blood group
RT   biosynthesis.";
RL   Nat. Struct. Biol. 9:685-690(2002).
RN   [20]
RP   X-RAY CRYSTALLOGRAPHY (1.55 ANGSTROMS) OF 64-345 OF MUTANT SER-234 IN
RP   COMPLEX WITH GLYCOPROTEIN FUCOSYL-GALACTOSE ANALOG.
RX   PubMed=12529355; DOI=10.1074/jbc.M212002200;
RA   Marcus S.L., Polakowski R., Seto N.O.L., Leinala E., Borisova S.,
RA   Blancher A., Roubinet F., Evans S.V., Palcic M.M.;
RT   "A single point mutation reverses the donor specificity of human blood
RT   group B-synthesizing galactosyltransferase.";
RL   J. Biol. Chem. 278:12403-12405(2003).
RN   [21]
RP   X-RAY CRYSTALLOGRAPHY (1.55 ANGSTROMS) OF 64-345 IN COMPLEXES WITH
RP   UDP; UDP-N-ACETYL-GALACTOSAMINE; UDP-GALACTOSE AND GLYCOPROTEIN
RP   FUCOSYL-GALACTOSE ANALOGS.
RX   PubMed=12972418; DOI=10.1074/jbc.M308770200;
RA   Nguyen H.P., Seto N.O.L., Cai Y., Leinala E.K., Borisova S.N.,
RA   Palcic M.M., Evans S.V.;
RT   "The influence of an intramolecular hydrogen bond in differential
RT   recognition of inhibitory acceptor analogs by human ABO(H) blood group
RT   A and B glycosyltransferases.";
RL   J. Biol. Chem. 278:49191-49195(2003).
RN   [22]
RP   X-RAY CRYSTALLOGRAPHY (1.49 ANGSTROMS) OF 64-354 OF MUTANTS SER-74 AND
RP   ARG-268 IN COMPLEXES WITH GLYCOPROTEIN FUCOSYL-GALACTOSE ANALOG AND
RP   UDP-N-ACETYL-GALACTOSAMINE.
RX   PubMed=15475562; DOI=10.1074/jbc.M500897200;
RA   Lee H.J., Barry C.H., Borisova S.N., Seto N.O.L., Zheng R.B.,
RA   Blancher A., Evans S.V., Palcic M.M.;
RT   "Structural basis for the inactivity of human blood group O2
RT   glycosyltransferase.";
RL   J. Biol. Chem. 280:525-529(2005).
RN   [23]
RP   X-RAY CRYSTALLOGRAPHY (1.49 ANGSTROMS) OF 64-354 OF HISTO-BLOOD GROUP
RP   GROUP A TRANSFERASE AND HISTO-BLOOD GROUP GROUP B TRANSFERASE IN
RP   COMPLEXES WITH GLYCOPROTEIN FUCOSYL-GALACTOSE ANALOGS.
RX   PubMed=16326711; DOI=10.1074/jbc.M507620200;
RA   Letts J.A., Rose N.L., Fang Y.R., Barry C.H., Borisova S.N.,
RA   Seto N.O.L., Palcic M.M., Evans S.V.;
RT   "Differential recognition of the type I and II H antigen acceptors by
RT   the human ABO(H) blood group A and B glycosyltransferases.";
RL   J. Biol. Chem. 281:3625-3632(2006).
RN   [24]
RP   X-RAY CRYSTALLOGRAPHY (1.67 ANGSTROMS) OF 64-354 OF MUTANTS ARG-214
RP   AND THR-214, COFACTOR, CHARACTERIZATION OF VARIANT ARG-214, AND
RP   MUTAGENESIS OF MET-214.
RX   PubMed=17259183; DOI=10.1074/jbc.M610998200;
RA   Persson M., Letts J.A., Hosseini-Maaf B., Borisova S.N., Palcic M.M.,
RA   Evans S.V., Olsson M.L.;
RT   "Structural effects of naturally occurring human blood group B
RT   galactosyltransferase mutations adjacent to the DXD motif.";
RL   J. Biol. Chem. 282:9564-9570(2007).
CC   -!- FUNCTION: This protein is the basis of the ABO blood group system.
CC       The histo-blood group ABO involves three carbohydrate antigens: A,
CC       B, and H. A, B, and AB individuals express a glycosyltransferase
CC       activity that converts the H antigen to the A antigen (by addition
CC       of UDP-GalNAc) or to the B antigen (by addition of UDP-Gal),
CC       whereas O individuals lack such activity.
CC   -!- CATALYTIC ACTIVITY: UDP-N-acetyl-alpha-beta-D-galactosamine +
CC       glycoprotein-alpha-L-fucosyl-(1->2)-D-galactose = UDP +
CC       glycoprotein-N-acetyl-alpha-D-galactosaminyl-(1->3)-(alpha-L-
CC       fucosyl-(1->2))-beta-D-galactose.
CC   -!- CATALYTIC ACTIVITY: UDP-alpha-D-galactose + alpha-L-fucosyl-
CC       (1->2)-D-galactosyl-R = UDP + alpha-D-galactosyl-(1->3)-(alpha-L-
CC       fucosyl-(1->2))-D-galactosyl-R.
CC   -!- COFACTOR:
CC       Name=Mn(2+); Xref=ChEBI:CHEBI:29035;
CC         Evidence={ECO:0000269|PubMed:17259183};
CC       Note=Binds 1 Mn(2+) ion per subunit.
CC       {ECO:0000269|PubMed:17259183};
CC   -!- PATHWAY: Protein modification; protein glycosylation.
CC   -!- SUBCELLULAR LOCATION: Golgi apparatus, Golgi stack membrane;
CC       Single-pass type II membrane protein. Secreted. Note=Membrane-
CC       bound form in trans cisternae of Golgi. Secreted into the body
CC       fluid.
CC   -!- DOMAIN: The conserved DXD motif is involved in cofactor binding.
CC       The manganese ion interacts with the beta-phosphate group of UDP
CC       and may also have a role in catalysis.
CC   -!- PTM: The soluble form derives from the membrane form by
CC       proteolytic processing.
CC   -!- POLYMORPHISM: Genetic variations in ABO define the ABO blood group
CC       system [MIM:616093]. The ABO blood group system is the most
CC       important blood group system in blood transfusion. The sequence
CC       shown here is that of the A transferase. The B form differs by a
CC       few residues substitution. Residues 266 and 268 are important for
CC       specificity. The O phenotype results from a single base frameshift
CC       in the N-terminal extremity of the gene, resulting in a severly
CC       truncated protein without catalytic activity.
CC       {ECO:0000269|PubMed:10462501, ECO:0000269|PubMed:12829588,
CC       ECO:0000269|PubMed:1449469, ECO:0000269|PubMed:15104652,
CC       ECO:0000269|PubMed:15489334, ECO:0000269|PubMed:18513251,
CC       ECO:0000269|PubMed:2121736, ECO:0000269|PubMed:7598760,
CC       ECO:0000269|PubMed:8839869, ECO:0000269|Ref.15, ECO:0000269|Ref.5,
CC       ECO:0000269|Ref.9}.
CC   -!- SIMILARITY: Belongs to the glycosyltransferase 6 family.
CC       {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=GGDB; Note=GlycoGene database;
CC       URL="http://jcggdb.jp/rcmg/ggdb/Homolog?cat=symbol&symbol=ABO";
CC   -!- WEB RESOURCE: Name=SeattleSNPs;
CC       URL="http://pga.gs.washington.edu/data/abo/";
CC   -!- WEB RESOURCE: Name=Functional Glycomics Gateway - GTase;
CC       Note=Histo-blood group ABO system transferase;
CC       URL="http://www.functionalglycomics.org/glycomics/molecule/jsp/glycoEnzyme/viewGlycoEnzyme.jsp?gbpId=gt_hum_450";
CC   -!- WEB RESOURCE: Name=Functional Glycomics Gateway - GTase;
CC       Note=Histo-blood group ABO system transferase;
CC       URL="http://www.functionalglycomics.org/glycomics/molecule/jsp/glycoEnzyme/viewGlycoEnzyme.jsp?gbpId=gt_hum_502";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; J05175; AAA36792.1; -; mRNA.
DR   EMBL; X84746; CAA59233.1; -; Genomic_DNA.
DR   EMBL; X84747; CAA59233.1; JOINED; Genomic_DNA.
DR   EMBL; X84748; CAA59233.1; JOINED; Genomic_DNA.
DR   EMBL; X84749; CAA59233.1; JOINED; Genomic_DNA.
DR   EMBL; X84750; CAA59233.1; JOINED; Genomic_DNA.
DR   EMBL; X84751; CAA59233.1; JOINED; Genomic_DNA.
DR   EMBL; X84752; CAA59233.1; JOINED; Genomic_DNA.
DR   EMBL; AF134412; AAD26572.1; -; mRNA.
DR   EMBL; AF134413; AAD26573.1; -; mRNA.
DR   EMBL; AF134414; AAD26574.1; -; mRNA.
DR   EMBL; AH007586; AAD26575.1; -; Genomic_DNA.
DR   EMBL; AH007587; AAD26576.1; -; Genomic_DNA.
DR   EMBL; AH007592; AAD26581.1; -; Genomic_DNA.
DR   EMBL; AJ920329; CAI79116.1; -; Genomic_DNA.
DR   EMBL; AM423110; CAM28424.1; -; Genomic_DNA.
DR   EMBL; AM492698; CAM34526.1; -; Genomic_DNA.
DR   EMBL; AM492699; CAM34527.1; -; Genomic_DNA.
DR   EMBL; AY268591; AAP03430.1; -; Genomic_DNA.
DR   EMBL; BC069595; AAH69595.1; -; mRNA.
DR   EMBL; BC111575; AAI11576.1; -; mRNA.
DR   EMBL; AJ536135; CAD60222.1; -; Genomic_DNA.
DR   EMBL; AJ536136; CAD60223.1; -; Genomic_DNA.
DR   EMBL; D82842; BAA11591.2; -; Genomic_DNA.
DR   EMBL; D82843; BAA11592.2; -; Genomic_DNA.
DR   EMBL; AF016622; AAB86462.1; -; Genomic_DNA.
DR   EMBL; AF448199; AAQ04662.1; -; Genomic_DNA.
DR   EMBL; AF448200; AAQ04663.1; -; Genomic_DNA.
DR   EMBL; AJ276689; CAB81779.1; -; Genomic_DNA.
DR   PIR; PC1165; PC1165.
DR   RefSeq; NP_065202.2; NM_020469.2.
DR   UniGene; Hs.654423; -.
DR   PDB; 1LZ0; X-ray; 1.80 A; A=64-354.
DR   PDB; 1LZ7; X-ray; 1.65 A; A=64-354.
DR   PDB; 1LZI; X-ray; 1.35 A; A=64-354.
DR   PDB; 1LZJ; X-ray; 1.32 A; A=64-354.
DR   PDB; 1R7T; X-ray; 2.09 A; A=64-345.
DR   PDB; 1R7U; X-ray; 1.61 A; A=64-345.
DR   PDB; 1R7V; X-ray; 2.09 A; A=64-345.
DR   PDB; 1R7X; X-ray; 1.97 A; A=64-345.
DR   PDB; 1R7Y; X-ray; 1.75 A; A=64-345.
DR   PDB; 1R80; X-ray; 1.65 A; A=64-345.
DR   PDB; 1R81; X-ray; 1.75 A; A=64-345.
DR   PDB; 1R82; X-ray; 1.55 A; A=64-345.
DR   PDB; 1WSZ; X-ray; 1.59 A; A=64-354.
DR   PDB; 1WT0; X-ray; 1.80 A; A=64-354.
DR   PDB; 1WT1; X-ray; 1.55 A; A=64-354.
DR   PDB; 1WT2; X-ray; 1.90 A; A=64-354.
DR   PDB; 1WT3; X-ray; 1.80 A; A=64-354.
DR   PDB; 1XZ6; X-ray; 1.55 A; A=64-354.
DR   PDB; 1ZHJ; X-ray; 1.59 A; A=64-354.
DR   PDB; 1ZI1; X-ray; 1.57 A; A=64-354.
DR   PDB; 1ZI3; X-ray; 1.69 A; A=64-354.
DR   PDB; 1ZI4; X-ray; 1.85 A; A=64-354.
DR   PDB; 1ZI5; X-ray; 1.55 A; A=64-354.
DR   PDB; 1ZIZ; X-ray; 1.49 A; A=64-354.
DR   PDB; 1ZJ0; X-ray; 1.67 A; A=64-354.
DR   PDB; 1ZJ1; X-ray; 1.65 A; A=64-354.
DR   PDB; 1ZJ2; X-ray; 1.69 A; A=64-354.
DR   PDB; 1ZJ3; X-ray; 1.69 A; A=64-354.
DR   PDB; 1ZJO; X-ray; 1.64 A; A=64-354.
DR   PDB; 1ZJP; X-ray; 1.59 A; A=64-354.
DR   PDB; 2A8U; X-ray; 1.69 A; A=64-354.
DR   PDB; 2A8W; X-ray; 1.59 A; A=64-354.
DR   PDB; 2I7B; X-ray; 1.99 A; A=64-354.
DR   PDB; 2O1F; X-ray; 1.99 A; A=64-354.
DR   PDB; 2O1G; X-ray; 1.71 A; A=64-354.
DR   PDB; 2O1H; X-ray; 1.67 A; A=64-354.
DR   PDB; 2PGV; X-ray; 1.79 A; A=64-354.
DR   PDB; 2PGY; X-ray; 2.39 A; A=64-354.
DR   PDB; 2RIT; X-ray; 1.43 A; A=64-354.
DR   PDB; 2RIX; X-ray; 1.75 A; A=64-354.
DR   PDB; 2RIY; X-ray; 1.55 A; A=64-354.
DR   PDB; 2RIZ; X-ray; 1.45 A; A=64-354.
DR   PDB; 2RJ0; X-ray; 1.52 A; A=64-354.
DR   PDB; 2RJ1; X-ray; 1.55 A; A=64-354.
DR   PDB; 2RJ4; X-ray; 1.47 A; A=64-354.
DR   PDB; 2RJ5; X-ray; 1.45 A; A=64-354.
DR   PDB; 2RJ6; X-ray; 1.41 A; A=64-354.
DR   PDB; 2RJ7; X-ray; 1.70 A; A=64-354.
DR   PDB; 2RJ8; X-ray; 1.69 A; A=64-354.
DR   PDB; 2RJ9; X-ray; 1.69 A; A=64-354.
DR   PDB; 2Y7A; X-ray; 2.06 A; A/B/C/D=64-354.
DR   PDB; 3I0C; X-ray; 1.55 A; A=69-354.
DR   PDB; 3I0D; X-ray; 1.90 A; A=69-354.
DR   PDB; 3I0E; X-ray; 1.81 A; A=69-354.
DR   PDB; 3I0F; X-ray; 1.56 A; A=69-354.
DR   PDB; 3I0G; X-ray; 1.40 A; A=69-354.
DR   PDB; 3I0H; X-ray; 2.00 A; A=69-354.
DR   PDB; 3I0I; X-ray; 1.90 A; X=69-354.
DR   PDB; 3I0J; X-ray; 1.48 A; A=69-354.
DR   PDB; 3I0K; X-ray; 2.20 A; A=69-354.
DR   PDB; 3I0L; X-ray; 1.60 A; A=69-354.
DR   PDB; 3IOH; X-ray; 1.25 A; A=64-354.
DR   PDB; 3IOI; X-ray; 1.45 A; A=64-354.
DR   PDB; 3IOJ; X-ray; 1.65 A; A/B=64-354.
DR   PDB; 3SX3; X-ray; 1.45 A; A=64-354.
DR   PDB; 3SX5; X-ray; 1.43 A; A=64-354.
DR   PDB; 3SX7; X-ray; 1.42 A; A=64-354.
DR   PDB; 3SX8; X-ray; 1.47 A; A=64-354.
DR   PDB; 3SXA; X-ray; 1.50 A; A=64-354.
DR   PDB; 3SXB; X-ray; 1.49 A; A=64-354.
DR   PDB; 3SXC; X-ray; 1.90 A; A=64-354.
DR   PDB; 3SXD; X-ray; 1.55 A; A=64-354.
DR   PDB; 3SXE; X-ray; 1.49 A; A=64-354.
DR   PDB; 3SXG; X-ray; 1.86 A; A=64-354.
DR   PDB; 3U0X; X-ray; 1.85 A; A/B=64-354.
DR   PDB; 3U0Y; X-ray; 1.60 A; A/B=64-354.
DR   PDB; 3V0L; X-ray; 1.75 A; A=64-354.
DR   PDB; 3V0M; X-ray; 1.68 A; A/B=64-354.
DR   PDB; 3V0N; X-ray; 1.75 A; A/B=64-354.
DR   PDB; 3V0O; X-ray; 1.65 A; A/B=64-354.
DR   PDB; 3V0P; X-ray; 1.90 A; A/B=64-354.
DR   PDB; 3V0Q; X-ray; 1.80 A; A/B=64-354.
DR   PDB; 3ZGF; X-ray; 1.70 A; A/B=64-354.
DR   PDB; 3ZGG; X-ray; 1.90 A; A=64-354.
DR   PDB; 4C2S; X-ray; 2.48 A; A/B=64-354.
DR   PDB; 4FQW; X-ray; 2.02 A; A=64-354.
DR   PDB; 4FRA; X-ray; 1.43 A; A=64-354.
DR   PDB; 4FRB; X-ray; 1.54 A; A=64-354.
DR   PDB; 4FRD; X-ray; 1.55 A; A=64-354.
DR   PDB; 4FRE; X-ray; 1.85 A; A=64-354.
DR   PDB; 4FRH; X-ray; 1.80 A; A=64-354.
DR   PDB; 4FRL; X-ray; 1.90 A; A=64-354.
DR   PDB; 4FRM; X-ray; 1.90 A; A=64-354.
DR   PDB; 4FRO; X-ray; 1.75 A; A=64-354.
DR   PDB; 4FRP; X-ray; 2.00 A; A=64-354.
DR   PDB; 4FRQ; X-ray; 2.35 A; A=64-354.
DR   PDB; 4GBP; X-ray; 2.15 A; A=64-354.
DR   PDB; 4KC1; X-ray; 1.50 A; A=64-346.
DR   PDB; 4KC2; X-ray; 1.70 A; A=64-346.
DR   PDB; 4KC4; X-ray; 1.60 A; A=64-346.
DR   PDB; 4KXO; X-ray; 2.00 A; A=64-354.
DR   PDBsum; 1LZ0; -.
DR   PDBsum; 1LZ7; -.
DR   PDBsum; 1LZI; -.
DR   PDBsum; 1LZJ; -.
DR   PDBsum; 1R7T; -.
DR   PDBsum; 1R7U; -.
DR   PDBsum; 1R7V; -.
DR   PDBsum; 1R7X; -.
DR   PDBsum; 1R7Y; -.
DR   PDBsum; 1R80; -.
DR   PDBsum; 1R81; -.
DR   PDBsum; 1R82; -.
DR   PDBsum; 1WSZ; -.
DR   PDBsum; 1WT0; -.
DR   PDBsum; 1WT1; -.
DR   PDBsum; 1WT2; -.
DR   PDBsum; 1WT3; -.
DR   PDBsum; 1XZ6; -.
DR   PDBsum; 1ZHJ; -.
DR   PDBsum; 1ZI1; -.
DR   PDBsum; 1ZI3; -.
DR   PDBsum; 1ZI4; -.
DR   PDBsum; 1ZI5; -.
DR   PDBsum; 1ZIZ; -.
DR   PDBsum; 1ZJ0; -.
DR   PDBsum; 1ZJ1; -.
DR   PDBsum; 1ZJ2; -.
DR   PDBsum; 1ZJ3; -.
DR   PDBsum; 1ZJO; -.
DR   PDBsum; 1ZJP; -.
DR   PDBsum; 2A8U; -.
DR   PDBsum; 2A8W; -.
DR   PDBsum; 2I7B; -.
DR   PDBsum; 2O1F; -.
DR   PDBsum; 2O1G; -.
DR   PDBsum; 2O1H; -.
DR   PDBsum; 2PGV; -.
DR   PDBsum; 2PGY; -.
DR   PDBsum; 2RIT; -.
DR   PDBsum; 2RIX; -.
DR   PDBsum; 2RIY; -.
DR   PDBsum; 2RIZ; -.
DR   PDBsum; 2RJ0; -.
DR   PDBsum; 2RJ1; -.
DR   PDBsum; 2RJ4; -.
DR   PDBsum; 2RJ5; -.
DR   PDBsum; 2RJ6; -.
DR   PDBsum; 2RJ7; -.
DR   PDBsum; 2RJ8; -.
DR   PDBsum; 2RJ9; -.
DR   PDBsum; 2Y7A; -.
DR   PDBsum; 3I0C; -.
DR   PDBsum; 3I0D; -.
DR   PDBsum; 3I0E; -.
DR   PDBsum; 3I0F; -.
DR   PDBsum; 3I0G; -.
DR   PDBsum; 3I0H; -.
DR   PDBsum; 3I0I; -.
DR   PDBsum; 3I0J; -.
DR   PDBsum; 3I0K; -.
DR   PDBsum; 3I0L; -.
DR   PDBsum; 3IOH; -.
DR   PDBsum; 3IOI; -.
DR   PDBsum; 3IOJ; -.
DR   PDBsum; 3SX3; -.
DR   PDBsum; 3SX5; -.
DR   PDBsum; 3SX7; -.
DR   PDBsum; 3SX8; -.
DR   PDBsum; 3SXA; -.
DR   PDBsum; 3SXB; -.
DR   PDBsum; 3SXC; -.
DR   PDBsum; 3SXD; -.
DR   PDBsum; 3SXE; -.
DR   PDBsum; 3SXG; -.
DR   PDBsum; 3U0X; -.
DR   PDBsum; 3U0Y; -.
DR   PDBsum; 3V0L; -.
DR   PDBsum; 3V0M; -.
DR   PDBsum; 3V0N; -.
DR   PDBsum; 3V0O; -.
DR   PDBsum; 3V0P; -.
DR   PDBsum; 3V0Q; -.
DR   PDBsum; 3ZGF; -.
DR   PDBsum; 3ZGG; -.
DR   PDBsum; 4C2S; -.
DR   PDBsum; 4FQW; -.
DR   PDBsum; 4FRA; -.
DR   PDBsum; 4FRB; -.
DR   PDBsum; 4FRD; -.
DR   PDBsum; 4FRE; -.
DR   PDBsum; 4FRH; -.
DR   PDBsum; 4FRL; -.
DR   PDBsum; 4FRM; -.
DR   PDBsum; 4FRO; -.
DR   PDBsum; 4FRP; -.
DR   PDBsum; 4FRQ; -.
DR   PDBsum; 4GBP; -.
DR   PDBsum; 4KC1; -.
DR   PDBsum; 4KC2; -.
DR   PDBsum; 4KC4; -.
DR   PDBsum; 4KXO; -.
DR   DisProt; DP00339; -.
DR   ProteinModelPortal; P16442; -.
DR   SMR; P16442; 64-354.
DR   BioGrid; 106546; 3.
DR   BindingDB; P16442; -.
DR   ChEMBL; CHEMBL2321639; -.
DR   CAZy; GT6; Glycosyltransferase Family 6.
DR   PhosphoSite; P16442; -.
DR   BioMuta; ABO; -.
DR   DMDM; 114949; -.
DR   PaxDb; P16442; -.
DR   PRIDE; P16442; -.
DR   DNASU; 28; -.
DR   GeneID; 28; -.
DR   KEGG; hsa:28; -.
DR   UCSC; uc004cda.1; human.
DR   CTD; 28; -.
DR   GeneCards; GC09M136130; -.
DR   HGNC; HGNC:79; ABO.
DR   MIM; 110300; gene.
DR   MIM; 616093; phenotype.
DR   neXtProt; NX_P16442; -.
DR   PharmGKB; PA24415; -.
DR   eggNOG; NOG43612; -.
DR   HOVERGEN; HBG003563; -.
DR   InParanoid; P16442; -.
DR   KO; K00709; -.
DR   OrthoDB; EOG7BZVSQ; -.
DR   PhylomeDB; P16442; -.
DR   BRENDA; 2.4.1.37; 2681.
DR   BRENDA; 2.4.1.40; 2681.
DR   UniPathway; UPA00378; -.
DR   EvolutionaryTrace; P16442; -.
DR   GeneWiki; ABO_(gene); -.
DR   GenomeRNAi; 28; -.
DR   NextBio; 97; -.
DR   PRO; PR:P16442; -.
DR   Proteomes; UP000005640; Unplaced.
DR   Genevisible; P16442; HS.
DR   GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR   GO; GO:0032580; C:Golgi cisterna membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0004381; F:fucosylgalactoside 3-alpha-galactosyltransferase activity; IEA:UniProtKB-EC.
DR   GO; GO:0004380; F:glycoprotein-fucosylgalactoside alpha-N-acetylgalactosaminyltransferase activity; IEA:UniProtKB-EC.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0006486; P:protein glycosylation; IEA:UniProtKB-UniPathway.
DR   Gene3D; 3.90.550.10; -; 1.
DR   InterPro; IPR005076; Glyco_trans_6.
DR   InterPro; IPR029044; Nucleotide-diphossugar_trans.
DR   PANTHER; PTHR10462; PTHR10462; 1.
DR   Pfam; PF03414; Glyco_transf_6; 1.
DR   SUPFAM; SSF53448; SSF53448; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Blood group antigen; Complete proteome;
KW   Direct protein sequencing; Glycoprotein; Glycosyltransferase;
KW   Golgi apparatus; Manganese; Membrane; Metal-binding; Polymorphism;
KW   Reference proteome; Secreted; Signal-anchor; Transferase;
KW   Transmembrane; Transmembrane helix.
FT   CHAIN         1    354       Histo-blood group ABO system transferase.
FT                                /FTId=PRO_0000012268.
FT   CHAIN        54    354       Fucosylglycoprotein alpha-N-
FT                                acetylgalactosaminyltransferase soluble
FT                                form.
FT                                /FTId=PRO_0000012269.
FT   TOPO_DOM      1     32       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     33     53       Helical; Signal-anchor for type II
FT                                membrane protein. {ECO:0000255}.
FT   TOPO_DOM     54    354       Lumenal. {ECO:0000255}.
FT   REGION      121    123       UDP-N-acetyl-galactosamine binding.
FT   REGION      211    213       UDP-N-acetyl-galactosamine binding.
FT   METAL       211    211       Manganese.
FT   METAL       213    213       Manganese.
FT   BINDING     126    126       UDP-N-acetyl-galactosamine.
FT   BINDING     233    233       Glycoprotein fucosyl-galactosyl group.
FT   BINDING     245    245       Glycoprotein fucosyl-galactosyl group.
FT   BINDING     303    303       Glycoprotein fucosyl-galactosyl group.
FT   BINDING     326    326       Glycoprotein fucosyl-galactosyl group.
FT   CARBOHYD    113    113       N-linked (GlcNAc...). {ECO:0000255}.
FT   VARIANT      35     35       G -> R (in dbSNP:rs8176696).
FT                                {ECO:0000269|Ref.9}.
FT                                /FTId=VAR_019147.
FT   VARIANT      36     36       V -> F (in dbSNP:rs688976).
FT                                {ECO:0000269|Ref.9}.
FT                                /FTId=VAR_019148.
FT   VARIANT      63     63       R -> H (in dbSNP:rs549446).
FT                                {ECO:0000269|Ref.9}.
FT                                /FTId=VAR_019149.
FT   VARIANT      74     74       P -> S (in dbSNP:rs512770).
FT                                {ECO:0000269|PubMed:12829588,
FT                                ECO:0000269|Ref.9}.
FT                                /FTId=VAR_019150.
FT   VARIANT      80     81       CR -> W.
FT                                /FTId=VAR_003408.
FT   VARIANT     156    156       P -> L (in allele A2; dbSNP:rs1053878).
FT                                {ECO:0000269|PubMed:12829588,
FT                                ECO:0000269|PubMed:7598760,
FT                                ECO:0000269|PubMed:8839869,
FT                                ECO:0000269|Ref.5, ECO:0000269|Ref.9}.
FT                                /FTId=VAR_003409.
FT   VARIANT     161    161       R -> H (in dbSNP:rs8176738).
FT                                {ECO:0000269|Ref.9}.
FT                                /FTId=VAR_019151.
FT   VARIANT     163    163       T -> M (in allele Aw08;
FT                                dbSNP:rs55756402).
FT                                {ECO:0000269|PubMed:12829588}.
FT                                /FTId=VAR_036738.
FT   VARIANT     176    176       R -> G (in group B transferase;
FT                                dbSNP:rs7853989).
FT                                {ECO:0000269|PubMed:12829588,
FT                                ECO:0000269|PubMed:15104652,
FT                                ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|PubMed:8839869,
FT                                ECO:0000269|Ref.15, ECO:0000269|Ref.5,
FT                                ECO:0000269|Ref.9}.
FT                                /FTId=VAR_003410.
FT   VARIANT     198    198       R -> W (in allele Aw07;
FT                                dbSNP:rs56223957).
FT                                /FTId=VAR_036739.
FT   VARIANT     199    199       R -> C (in dbSNP:rs8176739).
FT                                {ECO:0000269|Ref.9}.
FT                                /FTId=VAR_019152.
FT   VARIANT     214    214       M -> R (in allele Bel01; loss of
FT                                manganese binding and reduced catalytic
FT                                activity; dbSNP:rs55827808).
FT                                {ECO:0000269|PubMed:17259183,
FT                                ECO:0000269|PubMed:8839869}.
FT                                /FTId=VAR_036740.
FT   VARIANT     216    216       F -> I (in dbSNP:rs8176740).
FT                                {ECO:0000269|PubMed:8839869,
FT                                ECO:0000269|Ref.9}.
FT                                /FTId=VAR_019153.
FT   VARIANT     223    223       E -> D (in allele B106).
FT                                {ECO:0000269|PubMed:8839869}.
FT                                /FTId=VAR_036741.
FT   VARIANT     230    230       G -> R (in group B transferase; lower-
FT                                level protein expression and
FT                                intracellular cytoplasmic mislocation).
FT                                {ECO:0000269|PubMed:18513251}.
FT                                /FTId=VAR_055227.
FT   VARIANT     234    234       P -> A (in allele B(A)).
FT                                {ECO:0000269|PubMed:10462501}.
FT                                /FTId=VAR_072628.
FT   VARIANT     235    235       G -> S (in group B transferase;
FT                                dbSNP:rs8176743).
FT                                {ECO:0000269|PubMed:12829588,
FT                                ECO:0000269|PubMed:15104652,
FT                                ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|PubMed:18513251,
FT                                ECO:0000269|PubMed:8839869,
FT                                ECO:0000269|Ref.15, ECO:0000269|Ref.5,
FT                                ECO:0000269|Ref.9}.
FT                                /FTId=VAR_003411.
FT   VARIANT     257    257       P -> L (in dbSNP:rs8176745).
FT                                /FTId=VAR_033540.
FT   VARIANT     266    266       L -> M (in group B transferase;
FT                                dbSNP:rs8176746).
FT                                {ECO:0000269|PubMed:12829588,
FT                                ECO:0000269|PubMed:1449469,
FT                                ECO:0000269|PubMed:15104652,
FT                                ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|PubMed:18513251,
FT                                ECO:0000269|PubMed:8839869,
FT                                ECO:0000269|Ref.5, ECO:0000269|Ref.9}.
FT                                /FTId=VAR_003412.
FT   VARIANT     268    268       G -> A (in group B transferase;
FT                                dbSNP:rs8176747).
FT                                {ECO:0000269|PubMed:12829588,
FT                                ECO:0000269|PubMed:1449469,
FT                                ECO:0000269|PubMed:15104652,
FT                                ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|PubMed:18513251,
FT                                ECO:0000269|PubMed:8839869,
FT                                ECO:0000269|Ref.9}.
FT                                /FTId=VAR_003413.
FT   VARIANT     268    268       G -> R (in dbSNP:rs8176747).
FT                                {ECO:0000269|PubMed:12829588}.
FT                                /FTId=VAR_033541.
FT   VARIANT     277    277       V -> M (in dbSNP:rs8176748).
FT                                {ECO:0000269|PubMed:8839869,
FT                                ECO:0000269|Ref.9}.
FT                                /FTId=VAR_019154.
FT   VARIANT     288    288       M -> R. {ECO:0000269|PubMed:12829588}.
FT                                /FTId=VAR_036742.
FT   VARIANT     291    291       D -> N (in allele B104).
FT                                {ECO:0000269|PubMed:8839869}.
FT                                /FTId=VAR_036743.
FT   VARIANT     346    346       K -> M (in allele Bw08).
FT                                {ECO:0000269|PubMed:12829588,
FT                                ECO:0000269|Ref.15}.
FT                                /FTId=VAR_036744.
FT   VARIANT     352    352       R -> G (in allele A107).
FT                                {ECO:0000269|PubMed:8839869}.
FT                                /FTId=VAR_036745.
FT   VARIANT     352    352       R -> W (in allele A106 and allele B3).
FT                                {ECO:0000269|PubMed:8839869}.
FT                                /FTId=VAR_003414.
FT   MUTAGEN     214    214       M->T,V: Alters substrate specificity so
FT                                that both UDP-N-acetyl-D-galactosamine
FT                                and UDP-galactose are utilized.
FT                                {ECO:0000269|PubMed:17259183}.
FT   MUTAGEN     234    234       P->S: Alters substrate specificity of
FT                                group B transferase.
FT   MUTAGEN     303    303       E->A: Decreases specific activity of
FT                                group B transferase almost to zero.
FT                                {ECO:0000269|PubMed:12198488}.
FT   STRAND       82     84       {ECO:0000244|PDB:3IOH}.
FT   STRAND       93     95       {ECO:0000244|PDB:3IOH}.
FT   HELIX       102    111       {ECO:0000244|PDB:3IOH}.
FT   STRAND      115    122       {ECO:0000244|PDB:3IOH}.
FT   HELIX       124    129       {ECO:0000244|PDB:3IOH}.
FT   HELIX       130    140       {ECO:0000244|PDB:3IOH}.
FT   STRAND      145    154       {ECO:0000244|PDB:3IOH}.
FT   HELIX       156    158       {ECO:0000244|PDB:3IOH}.
FT   STRAND      168    174       {ECO:0000244|PDB:3IOH}.
FT   HELIX       181    198       {ECO:0000244|PDB:3IOH}.
FT   HELIX       200    203       {ECO:0000244|PDB:3IOH}.
FT   STRAND      205    210       {ECO:0000244|PDB:3IOH}.
FT   STRAND      212    216       {ECO:0000244|PDB:3IOH}.
FT   HELIX       222    224       {ECO:0000244|PDB:3IOH}.
FT   STRAND      226    232       {ECO:0000244|PDB:3IOH}.
FT   TURN        234    238       {ECO:0000244|PDB:3IOH}.
FT   HELIX       241    243       {ECO:0000244|PDB:3IOH}.
FT   STRAND      269    273       {ECO:0000244|PDB:3IOH}.
FT   HELIX       274    293       {ECO:0000244|PDB:3IOH}.
FT   TURN        299    301       {ECO:0000244|PDB:3IOH}.
FT   HELIX       302    312       {ECO:0000244|PDB:3IOH}.
FT   STRAND      316    319       {ECO:0000244|PDB:3IOH}.
FT   HELIX       321    323       {ECO:0000244|PDB:3IOH}.
FT   HELIX       327    330       {ECO:0000244|PDB:3IOH}.
FT   STRAND      341    343       {ECO:0000244|PDB:3IOH}.
FT   HELIX       348    351       {ECO:0000244|PDB:3SX3}.
SQ   SEQUENCE   354 AA;  40934 MW;  A03DA16E630C1608 CRC64;
     MAEVLRTLAG KPKCHALRPM ILFLIMLVLV LFGYGVLSPR SLMPGSLERG FCMAVREPDH
     LQRVSLPRMV YPQPKVLTPC RKDVLVVTPW LAPIVWEGTF NIDILNEQFR LQNTTIGLTV
     FAIKKYVAFL KLFLETAEKH FMVGHRVHYY VFTDQPAAVP RVTLGTGRQL SVLEVRAYKR
     WQDVSMRRME MISDFCERRF LSEVDYLVCV DVDMEFRDHV GVEILTPLFG TLHPGFYGSS
     REAFTYERRP QSQAYIPKDE GDFYYLGGFF GGSVQEVQRL TRACHQAMMV DQANGIEAVW
     HDESHLNKYL LRHKPTKVLS PEYLWDQQLL GWPAVLRKLR FTAVPKNHQA VRNP
//
